/PRNewswire/ The Pfizer/BioNTech BNT162b2 vaccine has been approved for the prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
/PRNewswire/ IdRamp, a leading decentralized identity platform provider for business that need passwordless zero trust security, announced today that it has.